← All Sponsors

SPONSOR

Takeda

Total Trials

9

Recruiting

9

Phases

Phase 4, Phase 3, Phase 2

Conditions studied: Crohn's Disease Thrombotic Thrombocytopenic Purpura (TTP)Acquired Hemophilia A Coagulation Disorder Fabry Disease Hodgkin Lymphoma Major Depressive Disorder Cytomegalovirus (CMV)Myelofibrosis

NCT06045754 Phase 4

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Crohn's Disease

NCT04683003 Phase 3

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura (TTP)

A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

Acquired Hemophilia A

NCT05156983 Phase 3

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

Coagulation Disorder

A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease

A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

Hodgkin Lymphoma

NCT07204314 Phase 3

A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder

Major Depressive Disorder

A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina

Cytomegalovirus (CMV)

NCT05037760 Phase 2

A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis